A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in ...

Study in Cancer Research used mice with one copy of p53 silenced and ER gene expression doubled. Minor alterations in p53 and estrogen receptor-alpha gene expression appear to play a role in ...

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma Authors retain all rights in ...

SAN ANTONIO – Among patients with hormone receptor-positive breast cancer treated with an aromatase inhibitor plus palbociclib (Ibrance), those who displayed a rising ESR1 mutation detected in their ...

Purpose: To determine whether progesterone receptor (PgR) status provides additional value to estrogen receptor (ER) status and improves prediction of benefit from endocrine treatment among patients ...

Emerging evidence suggests there may be a critical window for estrogen therapy to protect against cognitive decline later in ...

Roche has reported a phase 3 win for its oral selective estrogen receptor degrader (SERD), bouncing back from an earlier setback to deliver data that could support filings for approval in breast ...

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...

Scientists have revealed the molecular structure of a type of receptor that's crucial to brain development and function. 'This study shows the dominant assemblies and states of the GABA receptor. That ...